JENNIFER BELLIDO: Open Payments
NPI 1083123780 · MURFREESBORO, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$822 in 11 payments from 7 companies in 2025. Trend: 2023 $55 · 2024 $687 · 2025 $822
Food & beverage: $822
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 2 | $218 |
| Abbott Laboratories | 1 | $161 |
| ABBVIE INC. | 2 | $125 |
| Astellas Pharma US Inc | 1 | $102 |
| Averitas Pharma Inc. | 3 | $101 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $87 |
| Axsome Therapeutics, Inc. | 1 | $28 |
Products named: THORATEC HEARTMATE 3 LVAS IMPLANT KIT, VRAYLAR, Ozempic, Veozah, QUTENZA, CAPLYTA, Auvelity.
Industry payments across TN — which companies pay providers there.
